CAMBRIDGE: Abcam plc (Nasdaq: ABCM), a global leader in the supply of life science research tools, has announced that its shareholders have approved the proposal for Danaher Corporation (NYSE: DHR) to acquire all of the outstanding shares of Abcam for…
CAMBRIDGE, UK: Abcam plc, a global leader in the supply of life science research tools, has completed its acquisition of BioVision Inc from Boai NKY Medical Holdings Ltd. for total consideration of $340 million. The acquisition accelerates execution of Abcam’s…
CAMBRIDGE, UK: Abcam plc, a global leader in the supply of life science research tools, has entered into a definitive agreement to acquire BioVision Inc., a wholly owned subsidiary of Boai NKY Medical Holdings Ltd., for $340 million, a news…
LONDON: Avacta Group has entered into a global distribution agreement with ABCAM plcto sell the Group’s recently developed SARS-CoV-2 research ELISA Affimer reagents. Avacta has developed Affimer reagents which can be used in a high performance ELISA laboratory test to…
LONDON: Abcam plc, a global leader in the supply of life science research tools, announced the pricing of its offering of 8.945 million American Depositary Shares (ADSs) at a price of $17.50 per ADS, for aggregate proceeds of approximately $156.5…
LONDON: Abcam plc announced today the commencement of a registered offering of 8,945,218 American Depositary Shares (ADSs). Each ADS offered represents one ordinary share of Abcam. The ADSs are being offered in a registered public offering in the United States….